Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 51.28
-1.53 (-2.90%)
At close: Mar 9, 2026
SHA:688193 Market Cap
SHA:688193 has a market cap or net worth of 1.99 billion as of March 9, 2026. Its market cap has increased by 40.09% in one year.
Market Cap
1.99B
Enterprise Value
1.21B
Revenue
162.06M
Ranking
n/a
PE Ratio
213.67
Stock Price
51.28
Market Cap Chart
Since March 30, 2022, SHA:688193's market cap has decreased from 2.59B to 1.99B, a decrease of -23.23%. That is a compound annual growth rate of -6.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.05B | 9.18% |
| Dec 31, 2025 | 1.88B | 35.54% |
| Dec 31, 2024 | 1.38B | -23.32% |
| Dec 29, 2023 | 1.80B | -3.42% |
| Dec 30, 2022 | 1.87B | -27.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemclin Diagnostics | 2.98B |
| Medicalsystem Biotechnology | 3.92B |
| Guangdong Hybribio Biotech | 4.14B |
| Berry Genomics Co.,Ltd | 4.18B |
| Shanghai Labway Clinical Laboratory | 4.22B |
| Thalys Medical Technology Group | 4.78B |
| SMO ClinPlus CO.,LTD. | 5.06B |
| Cowealth Medical China | 6.80B |